History
Accreditation Program Background
Mission, Purpose and Goal
The mission is to promote quality practice in Histocompatibility and Immunogenetics through the objective and consistent evaluation of compliance with ASHI standards. The purpose of the accreditation program is to evaluate laboratory personnel, procedures and facilities to deterĀmine if they are in compliance with those published standards of ASHI and with those standards of organizations by which ASHI is deemed and which apply to the activities of that laboratory. Laboratories will be evaluated for the technology utilized and, if applicable, the clinical services provided.
The goals of the accreditation program are:
- To perform the evaluation process in an ethical, objective and timely fashion
- To promote the educational aspects of the accreditation process.
- To provide to various committees of the Society, data obtained in the accreditation process, which are useful for maintaining the Society's awareness of standard and novel procedures and methodologies.
A Brief History of the Accreditation Program . . .
With the objective of maintaining the highest standards of reliability and quality in histocompatibility testing laboratories, ASHI established its accreditation program in 1974. ASHI Accreditation was originally and still remains voluntary. Its purpose is to evaluate laboratory personnel, procedures, and facilities to determine if they are in compliance with ASHI standards; to promote the educational aspects of the accreditation process, particularly in assisting laboratories in the correction of deficiencies; to provide expert advice and assistance to committees of the society; and to maintain the society's awareness of standard and novel procedures and methodologies. Categories and techniques of accreditation include:
Areas Of Accreditation
| HCS/BM Transplantation: Related Donor |
| HCS/BM Transplantation: Unrelated Donor |
| Solid Organ Transplantation: Deceased Donor |
| Solid Organ Transplantation: Live Donor |
| Parentage Testing |
| Histocompatibility Testing for Other Clinical Purposes |
| Transfusion Support |
Techniques
| Technologies | Methods |
| Serology I | CDC |
| Serology II | CDC |
| DNA I | SSP, SSO, SBT |
| DNA II | SSP, SSO, SBT |
| Antibody Screening | CDC, ELISA, Flow, Microarray |
| Antibody Identification | CDC, ELISA, Flow, Microarray |
| Crossmatch | CDC, Flow, Microarray, Solid phase |
| Engraftment / Fragment Analysis | SBT, STR, VNTR |
| Cellular assays | MLC, Immune Monitoring |
| Flow Cytometry | Immunophenotyping, CD34 Enumeration |
This voluntary program has accredited over 200 histocompatibility laboratories and is administered through the ASHI Accreditation Review Board. The Centers for Medicare and Medicaid (CMS), National Marrow Donor Program (NMDP), United Network for Organ Sharing (UNOS), The American Foundation for Donation and Transplantation (AFDT, formerly SEOPF) and the states of California, Florida, Oregon and Washington grant deemed status to ASHI accredited labs. The Joint Commission on Accreditation of Healthcare Organizations (JCAHO) recognizes ASHI Accreditation with Complimentary status. Any of these organizations may do their own inspections, however, for validation purposes or complaint response.
Accreditation Program Historical Timeline
ASHI Accreditation was originally and still remains voluntary.
| 1974 | Establishment of the Accreditation Committee |
| 1976 | Start of Laboratory Evaluations |
| 1986 | Upon recognition of the increasing diversity of histocompatibility testing and the growing number of laboratories seeking ASHI Accreditation, the ASHI Council charged the Accreditation Committee to revise the program to make it more specific to the activities of the laboratory |
| 1987 | The
reorganization program began in August 1986 and became effective
in January 1987
Accreditation was granted or denied for specific laboratory activities Recognizing the need for a responsive program, which could perform a thorough and unbiased evaluation of histocompatibility laboratories performing testing for organ transplantation, UNOS contracted with ASHI to perform evaluation of laboratories applying for membership |
| 1988 | ADTF (formerly SEOPF) adopted a policy of accepting ASHI Accreditation as a recognized approval of its member laboratories |
| 1990 | The NMDP contracted with ASHI for laboratory evaluation services |
| 1992 | NMDP began requiring ASHI Accreditation for its contract and transplant center laboratories |
| 1995 | The ASHI Accreditation program achieved its deemed status with CMS (formerly HCFA) and CLIA |
| 1997 | Deemed
status with JCAHO, State of New York, Florida, Oregon and
Washington. |
| 1998 | New name given, Accreditation Program. New structure, Accreditation Board, and process defined. |
| 2004 | ASHI Standards, Checklists, Guidelines, Inspection Packets, and Operations Manual updated. |
| 2005 | CMS grants deemed status to ASHI as an accrediting organization for a period of 6 years, March 25, 2011 |
| 2005 | New ASHI Accreditation Program debuts, May 1, 2005 including a new online Interim Application and online Inspection’s Checklist |
| 2006 | The ARB debuts the online On Site Application Packet |
